238 related articles for article (PubMed ID: 25620201)
1. (-)-epigallocatechin-3-gallate inhibits fibrillogenesis of chicken cystatin.
Wang N; He J; Chang AK; Wang Y; Xu L; Chong X; Lu X; Sun Y; Xia X; Li H; Zhang B; Song Y; Kato A; Jones GW
J Agric Food Chem; 2015 Feb; 63(5):1347-51. PubMed ID: 25620201
[TBL] [Abstract][Full Text] [Related]
2. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate.
Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653
[TBL] [Abstract][Full Text] [Related]
4. Prevention of amyloid fibril formation of amyloidogenic chicken cystatin by site-specific glycosylation in yeast.
He J; Song Y; Ueyama N; Saito A; Azakami H; Kato A
Protein Sci; 2006 Feb; 15(2):213-22. PubMed ID: 16434741
[TBL] [Abstract][Full Text] [Related]
5. A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer.
Nie RZ; Zhu W; Peng JM; Ge ZZ; Li CM
Biochimie; 2016 Jun; 125():204-12. PubMed ID: 27079519
[TBL] [Abstract][Full Text] [Related]
6. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant amyloidogenic chicken cystatin mutant I66Q expressed in yeast.
He J; Song Y; Ueyama N; Harada A; Azakami H; Kato A
J Biochem; 2005 Apr; 137(4):477-85. PubMed ID: 15858171
[TBL] [Abstract][Full Text] [Related]
8. Appendant structure plays an important role in amyloidogenic cystatin dimerization prior to domain swapping.
Yu Y; Liu X; He J; Zhang M; Li H; Wei D; Song Y
J Biomol Struct Dyn; 2012; 30(1):102-12. PubMed ID: 22571436
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin Gallate Remodels Fibrils of Lattice Corneal Dystrophy Protein, Facilitating Proteolytic Degradation and Preventing Formation of Membrane-Permeabilizing Species.
Stenvang M; Christiansen G; Otzen DE
Biochemistry; 2016 Apr; 55(16):2344-57. PubMed ID: 27042751
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.
Franko A; Rodriguez Camargo DC; Böddrich A; Garg D; Rodriguez Camargo A; Rathkolb B; Janik D; Aichler M; Feuchtinger A; Neff F; Fuchs H; Wanker EE; Reif B; Häring HU; Peter A; Hrabě de Angelis M
Sci Rep; 2018 Jan; 8(1):1116. PubMed ID: 29348618
[TBL] [Abstract][Full Text] [Related]
11. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
[TBL] [Abstract][Full Text] [Related]
12. Quinopeptide formation associated with the disruptive effect of epigallocatechin-gallate on lysozyme fibrils.
Cao N; Zhang YJ; Feng S; Zeng CM
Int J Biol Macromol; 2015; 78():389-95. PubMed ID: 25931397
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation to investigate the impact of disulfide bond formation on conformational stability of chicken cystatin I66Q mutant.
He J; Xu L; Zou Z; Ueyama N; Li H; Kato A; Jones GW; Song Y
J Biomol Struct Dyn; 2013 Oct; 31(10):1101-10. PubMed ID: 23030454
[TBL] [Abstract][Full Text] [Related]
14. Distinct structural changes in wild-type and amyloidogenic chicken cystatin caused by disruption of C95-C115 disulfide bond.
Chong X; Lu X; Wang Y; Chang AK; Xu L; Wang N; Sun Y; Jones GW; Song Y; Song YB; He J
J Biomol Struct Dyn; 2016 Dec; 34(12):2679-2687. PubMed ID: 26629743
[TBL] [Abstract][Full Text] [Related]
15. Structural and dynamic properties of a new amyloidogenic chicken cystatin mutant I108T.
Yu Y; Wang Y; He J; Liu Y; Li H; Zhang H; Song Y
J Biomol Struct Dyn; 2010 Apr; 27(5):641-9. PubMed ID: 20085381
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2.
Chandrashekaran IR; Adda CG; MacRaild CA; Anders RF; Norton RS
Biochemistry; 2010 Jul; 49(28):5899-908. PubMed ID: 20545323
[TBL] [Abstract][Full Text] [Related]
17. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.
Ferreira N; Cardoso I; Domingues MR; Vitorino R; Bastos M; Bai G; Saraiva MJ; Almeida MR
FEBS Lett; 2009 Nov; 583(22):3569-76. PubMed ID: 19861125
[TBL] [Abstract][Full Text] [Related]
18. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping.
Janowski R; Kozak M; Jankowska E; Grzonka Z; Grubb A; Abrahamson M; Jaskolski M
Nat Struct Biol; 2001 Apr; 8(4):316-20. PubMed ID: 11276250
[TBL] [Abstract][Full Text] [Related]
19. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils.
Palhano FL; Lee J; Grimster NP; Kelly JW
J Am Chem Soc; 2013 May; 135(20):7503-10. PubMed ID: 23611538
[TBL] [Abstract][Full Text] [Related]
20. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
